Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir or Nitazoxanide for COVID-19
NCT04498936Phase 4Completed
- Sponsor
- Assiut University
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Harvoni, nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Assiut University. Started Jul 2020; status: completed.
02
Drugs
Harvoninitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04498936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498936.